![Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies | SpringerLink Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-020-00911-0/MediaObjects/40262_2020_911_Fig1_HTML.png)
Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies | SpringerLink
![ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER](https://www.natap.org/2008/images/042508/mult-1.gif)
ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER
Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs | PLOS Medicine
![Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration - Ophthalmology Retina Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration - Ophthalmology Retina](https://ophthalmologyretina.org/cms/attachment/b05c6304-2707-4385-9751-ab974472d1ea/figs1_lrg.jpg)
Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration - Ophthalmology Retina
![Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio](https://www.gossamerbio.com/wp-content/uploads/P903.png)
Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio
![Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection ... Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection ...](https://www.thelancet.com/cms/attachment/c3a2aad3-a0ef-4dce-acf3-6b857fa80786/gr1_lrg.jpg)
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection ...
![Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291815011777-gr1.jpg)
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect
![A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-018-0763-9/MediaObjects/12890_2018_763_Fig3_HTML.png)
A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary
![Schematic of the ECG timepoints and meals in the single-ascending dose... | Download Scientific Diagram Schematic of the ECG timepoints and meals in the single-ascending dose... | Download Scientific Diagram](https://www.researchgate.net/publication/318833802/figure/fig2/AS:627807579299840@1526692399903/Schematic-of-the-ECG-timepoints-and-meals-in-the-single-ascending-dose-SAD-and.png)
Schematic of the ECG timepoints and meals in the single-ascending dose... | Download Scientific Diagram
![Traditional Process First in Human Single Ascending Dose Multiple Ascending Dose U.S.A. Japan Phase II Phase III NDA in Japan Phase II Phase III NDA in. - ppt download Traditional Process First in Human Single Ascending Dose Multiple Ascending Dose U.S.A. Japan Phase II Phase III NDA in Japan Phase II Phase III NDA in. - ppt download](https://slideplayer.com/4594482/15/images/slide_1.jpg)
Traditional Process First in Human Single Ascending Dose Multiple Ascending Dose U.S.A. Japan Phase II Phase III NDA in Japan Phase II Phase III NDA in. - ppt download
![Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206 | Antimicrobial Agents and Chemotherapy Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206 | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00739-21/asset/28998e59-614c-40da-8ed2-2c2755645df5/assets/images/large/aac.00739-21-f002.jpg)
Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206 | Antimicrobial Agents and Chemotherapy
![CR TidBit – Single Ascending Dose to Multiple Ascending Dose. | AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India CR TidBit – Single Ascending Dose to Multiple Ascending Dose. | AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India](https://auroushealthcare.files.wordpress.com/2014/07/sad-mad2.jpg)